A detailed history of Wellington Management Group LLP transactions in Xencor Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 48,870 shares of XNCR stock, worth $989,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,870
Previous 42,316 15.49%
Holding current value
$989,617
Previous $936,000 1.18%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$18.21 - $24.5 $119,348 - $160,573
6,554 Added 15.49%
48,870 $925,000
Q1 2024

May 15, 2024

BUY
$18.65 - $26.52 $789,193 - $1.12 Million
42,316 New
42,316 $936,000
Q4 2023

Feb 12, 2024

BUY
$16.53 - $21.42 $684,176 - $886,573
41,390 New
41,390 $878,000
Q1 2020

May 14, 2020

SELL
$20.69 - $37.79 $267,769 - $489,078
-12,942 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$32.75 - $41.43 $423,850 - $536,187
12,942 New
12,942 $445,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.21B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.